MAYNE PHARMA INC FDA Approval ANDA 208764

ANDA 208764

MAYNE PHARMA INC

FDA Drug Application

Application #208764

Application Sponsors

ANDA 208764MAYNE PHARMA INC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL25MG0EXEMESTANEEXEMESTANE

FDA Submissions

UNKNOWN; ORIG1AP2019-08-08STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

MAYNE PHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208764
            [companyName] => MAYNE PHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"EXEMESTANE","activeIngredients":"EXEMESTANE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/08\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-08-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.